Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.81 USD | +1.69% | -2.69% | -38.64% |
May. 09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 3.75M | Sales 2025 * | 10.35M | Capitalization | 67.93M |
---|---|---|---|---|---|
Net income 2024 * | -102M | Net income 2025 * | -90M | EV / Sales 2024 * | 51.1 x |
Net Debt 2024 * | 124M | Net Debt 2025 * | 123M | EV / Sales 2025 * | 18.4 x |
P/E ratio 2024 * |
-0.66
x | P/E ratio 2025 * |
-0.95
x | Employees | 74 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.93% |
Latest transcript on BioXcel Therapeutics, Inc.
1 day | +1.69% | ||
1 week | -2.69% | ||
1 month | -28.17% | ||
3 months | -43.08% | ||
6 months | -52.37% | ||
Current year | -38.64% |
Managers | Title | Age | Since |
---|---|---|---|
Vimal Mehta
FOU | Founder | 63 | 17-03-28 |
Director of Finance/CFO | 66 | 17-09-30 | |
Frank Yocca
CTO | Chief Tech/Sci/R&D Officer | 68 | 17-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 22-06-30 |
Peter Mueller
CHM | Chairman | 68 | 17-03-31 |
Sandeep Laumas
BRD | Director/Board Member | 56 | 17-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 9 M€ | +9.86% | - | |
0.00% | 1,487 M€ | +7.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.81 | +1.69% | 1,839,581 |
24-05-30 | 1.78 | -0.56% | 492,565 |
24-05-29 | 1.79 | -3.76% | 341,678 |
24-05-28 | 1.86 | -.--% | 563,392 |
24-05-24 | 1.86 | +0.54% | 555,627 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.64% | 67.93M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- BTAI Stock